MENLO PARK, Calif.--Progenitor has been issued a patent that relates to the genes encoding the human leptin receptor and naturally occurring human leptin receptor variants, expression vectors, and genetically engineered cells incorporating the genes and methods for producing leptin receptor molecules in genetically engineered cells.
The patent is the second issued to Progenitor. The company has two other allowed patents, and another four pending.